The effectiveness of methods for perioperative pain relief in patients with burns

Authors: Sorokina E.Y., Buriak T.A., Leshev D.P., State Institution «Dnipropetrovs’k medical academy» of the Ministry of Heals of Ukraine


Summary

Predictors of the severity of pain after a thermal trauma vary depending on the phase of the burn wound healing. For the analysis of a homogeneous sample of victims with a deep burn, patients with a total burn injury area of 15.4 ± 4.2%, who underwent autodermoplasty of the skin during 14 days after the thermal trauma.

Patients were divided into two groups: first group (n = 30), which in the perioperative period was anesthetized with Sertofen (dexketoprofen trometamol 50 mg / 2 ml 2 ml 3 times a day) in the intensive care complex. The first dose of the drug was administered intraoperatively to prevent analgesia. Follow-up anesthesia with Sertofen was carried out at 50 mg / 2 ml 2 ml 3 times a day for 2-3 days postoperative period. Second group (n = 28) – in the nearest postoperative period received a narcotic analgesic (promedol 2% 1 ml), as an analgesia used analgin (metamizole sodium). All patients in the first and second observation groups underwent surgical treatment of skin burns at 12.5 ± 2.8 and 10.3 ± 2.5 days of burn disease, respectively.

It was established that in patients of first group with perioperative anesthesia with Sertofen, was observed more even decrease of pain syndrome, a tendency to lower blood levels of cortisol and stable blood glucose values.

It was concluded, that in perioperative period in patients with thermal trauma the use of dexketoprofen trometamol (Sertofen), causes effective and safe anesthesia and can be recommended in this group of patients.

Keyw ords: thermal trauma, autodermopl asty, perioperati ve anesthesia, sertofen (dexketoprofen trometamol).

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design